SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Oncotelic Unveils Four-Gene HCC Signature for Sapu003 Trials

Oncotelic said a peer-reviewed study identified a four-gene prognostic signature using its PDAOAI platform, validated in a 203-patient Japanese cohort, to stratify patients for Sapu003 clinical development.

OTLC

Related stories